Phosphodiesterase 3 Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Phosphodiesterase 3 Inhibitor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | AGRYLIN | anagrelide hydrochloride | CAPSULE;ORAL | 020333-002 | Mar 14, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Takeda Pharms Usa | AGRYLIN | anagrelide hydrochloride | CAPSULE;ORAL | 020333-001 | Mar 14, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | ANAGRELIDE HYDROCHLORIDE | anagrelide hydrochloride | CAPSULE;ORAL | 076683-001 | Apr 18, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | ANAGRELIDE HYDROCHLORIDE | anagrelide hydrochloride | CAPSULE;ORAL | 076683-002 | Apr 18, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ivax Sub Teva Pharms | ANAGRELIDE HYDROCHLORIDE | anagrelide hydrochloride | CAPSULE;ORAL | 076468-001 | Apr 18, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ivax Sub Teva Pharms | ANAGRELIDE HYDROCHLORIDE | anagrelide hydrochloride | CAPSULE;ORAL | 076468-002 | Apr 18, 2005 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
